Middle East and Africa Dry Eye Syndrome Market – Industry Trends and Forecast to 2026

  • Pharmaceutical
  • Published Report
  • Jul 2019
  • MEA
  • 350 Pages
  • No of Tables: 75
  • No of Figures: 28

Middle East and Africa Dry Eye Syndrome Market  By Product Type (Tear stimulators, Artificial tears, Secretagogue, Others), Dosage Type (Liquid, Semi-solid, Others), Drug Class (Lubricating Agents, Cholinergics, Anti-Inflammatory, Anti-Infectives, Anti-Allergics, Others), Dose( Unit dose, Multi-dose), Medication Type( Prescription (Rx) Drugs, Over The Counter (OTC) Drugs), Container Type (Unit-Dose Vials, Bottles, Tubes), Packaging Type( Plastic, Aluminium, Glass), Type (Brands, Generics), End Users (Home Healthcare, Hospitals, Clinics, Others), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Others), Country (Brazil, Rest of Middle East And Africa) - Industry Trends and Forecast to 2026

Dry eye is a multifactorial disease of the tears and ocular surface that causes symptoms of disquiet visual disturbance and tears film variability with possible damage to the ocular surface. It is escorted increase in tear film osmolality and ocular surface inflammation which may result in substantial damage of eye. The symptoms of dry eye syndrome includes eye redness, blurred vision and eye fatigue, Watery eyes, which are the body's response to the irritation of dry eyes such as a stinging burning and scratchy sensation in eyes.

Middle East and Africa dry eye syndrome market is projected to register a steady CAGR in the forecast period 2019 to 2026.

Segmentation: Middle East and Africa Dry Eye Syndrome Market

The Middle East And Africa  dry eye syndrome market is segmented into ten notable segments on the basis of product type, dosage type, drug class, dose, medication type, container type, packaging type, type, end user and distribution channel.

·         On the basis of product type, the market is segmented into tear stimulators, artificial tears, secretagogue and others

·         On the basis of dosage type, the market is segmented into liquid, semi solid and others

·         On the basis of drug class, the market is segmented into anti-inflammatory, lubricating agents, anti-infectives, anti-allergics, cholinergics and others

·         On the basis of dose, the market is segmented into multi dose and unit dose

·         On the basis of medication type, the market is segmented into prescription (RX) drugs, and over the counter (OTC) drugs

·         On the basis of container type, the market is segmented into unit dose vials, bottles, and tubes

·         On the basis of packaging type, the market is segmented into plastic, glass and aluminium

·         On the basis of type, the market is segmented into generics and brands.

·         On the basis of end user, the market is segmented into home healthcare, hospitals, clinics, and others

·         On the basis of distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, online pharmacies and others

Competitive Analysis: Middle East and Africa Dry Eye Syndrome Market

Some of the major players operating in the Middle East And Africa  dry eye syndrome market are Allergan, Bausch & Lomb Incorporated, Novartis Ag, Johnson & Johnson Services, Inc., Prestige Consumer Healthcare, Inc., Akorn, Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Novaliq Gmbh, Santen Pharmaceutical Co., Ltd., Cardinal Health, Alembic Pharmaceuticals Limited., Cipla Inc., Perrigo Company Plc, Senju Pharmaceutical Co. Ltd., Horus Pharma, Rohto Pharmaceutical Co., Ltd., Visufarma, Hubrx and others.

Product Launch

·         In May 2018, Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd (Israel), launched Teva-Cyclosporine. It is a generic version of Allergen’s Restasis. The major advantage of this product launch is that it will help the company in growing its market share in the dry eye treatment, as more than 29.0 % of Canada population suffers from the dry eye syndrome.

Research Methodology : Middle East and Africa Dry Eye Syndrome Market

Primary Respondents:

Key Opinion Leaders (KOL’s): Manufacturers, Researchers, Distributors, Bakers and Food Industrialists.

Industry Participants: CEO’s, V.P.’s, Marketing/Product Managers, Market Intelligence Managers and National Sales Managers.


SKU-

TABLE 1 AGEING WORLD POPULATION

TABLE 2 MIDDLE EAST AND AFRICA DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 3 MIDDLE EAST AND AFRICA TEAR STIMULATORS IN DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 4 MIDDLE EAST AND AFRICA DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 5 MIDDLE EAST AND AFRICA DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2016-2026 (USD MILLION)

TABLE 6 MIDDLE EAST AND AFRICA LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2016-2026 (USD MILLION)

TABLE 7 MIDDLE EAST AND AFRICA LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2016-2026 (USD MILLION)

TABLE 8 MIDDLE EAST AND AFRICA SEMI SOLID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2016-2026 (USD MILLION)

TABLE 9 MIDDLE EAST AND AFRICA DIGITAL IN DRY EYE SYNDROME MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)

TABLE 10 MIDDLE EAST AND AFRICA OTHERS IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 11 MIDDLE EAST AND AFRICA DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017-2026 (USD MILLION)

TABLE 12 MIDDLE EAST AND AFRICA ANTI-INFLAMMATORY IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 13 MIDDLE EAST AND AFRICA LUBRICATING AGENT IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 14 MIDDLE EAST AND AFRICA ANTI-INFECTIVE IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 15 MIDDLE EAST AND AFRICA ANTI-ALLERGIC IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 16 MIDDLE EAST AND AFRICA CHOLINERGIC IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 17 MIDDLE EAST AND AFRICA OTHERS IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 18 MIDDLE EAST AND AFRICA DRY EYE SYNDROME MARKET, BY DOSE, 2017-2026 (USD MILLION)

TABLE 19 MIDDLE EAST AND AFRICA MULTI DOSE IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 20 MIDDLE EAST AND AFRICA UNIT DOSE IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 21 MIDDLE EAST AND AFRICA DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017-2026 (USD MILLION)

TABLE 22 MIDDLE EAST AND AFRICA PRESCRIPTION (RX) DRUGS IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 23 MIDDLE EAST AND AFRICA OVER THE COUNTER (OTC) DRUGS IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 24 MIDDLE EAST AND AFRICA DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017-2026 (USD MILLION)

TABLE 25 MIDDLE EAST AND AFRICA UNIT DOSE VIALS IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 26 MIDDLE EAST AND AFRICA BOTTLES IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 27 MIDDLE EAST AND AFRICA TUBES IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 28 MIDDLE EAST AND AFRICA DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017-2026 (USD MILLION)

TABLE 29 MIDDLE EAST AND AFRICA PLASTIC IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 30 MIDDLE EAST AND AFRICA GLASS IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 31 MIDDLE EAST AND AFRICA ALUMINUM IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 32 MIDDLE EAST AND AFRICA DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 33 MIDDLE EAST AND AFRICA GENERICS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 34 MIDDLE EAST AND AFRICA BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 35 MIDDLE EAST AND AFRICA BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 36 MIDDLE EAST AND AFRICA DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 37 MIDDLE EAST AND AFRICA HOME HEALTHCARE IN DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 38 MIDDLE EAST AND AFRICA HOSPITALS IN DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 39 MIDDLE EAST AND AFRICA CLINICS IN DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 40 MIDDLE EAST AND AFRICA OTHERS IN DRY EYE SYNDROME MARKET, BY END USER, 2016-2026 (USD MILLION)

TABLE 41 MIDDLE EAST AND AFRICA DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 42 MIDDLE EAST AND AFRICA HOSPITAL PHARMACY IN DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 43 MIDDLE EAST AND AFRICA RETAIL PHARMACY IN DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 44 MIDDLE EAST AND AFRICA ONLINE PHARMACY IN DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 45 MIDDLE EAST AND AFRICA OTHERS IN DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2016-2026 (USD MILLION)

TABLE 46 MIDDLE EAST AND AFRICA DRY EYE SYNDROME MARKET, BY COUNTRY, 2017– 2026 (USD MILLION)

TABLE 47 MIDDLE EAST AND AFRICA DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017– 2026 (USD MILLION)

TABLE 48 MIDDLE EAST AND AFRICA TEAR STIMULATORS MARKET, BY PRODUCT TYPE, 2017– 2026 (USD MILLION)

TABLE 49 MIDDLE EAST AND AFRICA TEAR STIMULATORS MARKET, BY DOSAGE TYPE, 2017– 2026 (USD MILLION)

TABLE 50 MIDDLE EAST AND AFRICA LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017– 2026 (USD MILLION)

TABLE 51 MIDDLE EAST AND AFRICA SEMI-SOLIDS IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017– 2026 (USD MILLION)

TABLE 52 MIDDLE EAST AND AFRICA DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017– 2026 (USD MILLION)

TABLE 53 MIDDLE EAST AND AFRICA DRY EYE SYNDROME MARKET, BY DOSE, 2017– 2026 (USD MILLION)

TABLE 54 MIDDLE EAST AND AFRICA DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017– 2026 (USD MILLION)

TABLE 55 MIDDLE EAST AND AFRICA DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017– 2026 (USD MILLION)

TABLE 56 MIDDLE EAST AND AFRICA DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017– 2026 (USD MILLION)

TABLE 57 MIDDLE EAST AND AFRICA DRY EYE SYNDROME MARKET, BY TYPE, 2017– 2026 (USD MILLION)

TABLE 58 MIDDLE EAST AND AFRICA BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017– 2026 (USD MILLION)

TABLE 59 MIDDLE EAST AND AFRICA DRY EYE SYNDROME MARKET, BY END USER, 2017– 2026 (USD MILLION)

TABLE 60 MIDDLE EAST AND AFRICA DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017– 2026 (USD MILLION)

TABLE 61 SOUTH AFRICA DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017– 2026 (USD MILLION)

TABLE 62 SOUTH AFRICA TEAR STIMULATORS MARKET, BY PRODUCT TYPE, 2017– 2026 (USD MILLION)

TABLE 63 SOUTH AFRICA TREATMENT MARKET, BY DOSAGE TYPE, 2017– 2026 (USD MILLION)

TABLE 64 SUTH AMERICA LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017– 2026 (USD MILLION)

TABLE 65 SOUTH AFRICA SEMI-SOLIDS IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017– 2026 (USD MILLION)

TABLE 66 SOUTH AFRICA DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017– 2026 (USD MILLION)

TABLE 67 SOUTH AFRICA DRY EYE SYNDROME MARKET, BY DOSE, 2017– 2026 (USD MILLION)

TABLE 68 SOUTH AFRICA DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017– 2026 (USD MILLION)

TABLE 69 SOUTH AFRICA DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017– 2026 (USD MILLION)

TABLE 70 SOUTH AFRICA DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017– 2026 (USD MILLION)

TABLE 71 SOUTH AFRICA DRY EYE SYNDROME MARKET, BY TYPE, 2017– 2026 (USD MILLION)

TABLE 72 SOUTH AFRICA BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017– 2026 (USD MILLION)

TABLE 73 SOUTH AFRICA DRY EYE SYNDROME MARKET, BY END USER, 2017– 2026 (USD MILLION)

TABLE 74 SOUTH AFRICA DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017– 2026 (USD MILLION)

TABLE 75 REST OF MIDDLE EAST AND AFRICA DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017– 2026 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
BUY NOW ADD TO CART
Why Choose Us
REQUEST FOR SAMPLE